Hemostatic complications associated with paraproteinemias

Area of Science:

• Hematology
• Oncology

Background:

• Hemorrhagic events are frequent in lymphoproliferative disorders (LPDs).
• Bleeding arises from factors like vascular infiltration, hyperviscosity, thrombocytopenia, and coagulopathies.
• Unique hemostatic derangements specific to paraprotein-expressing LPDs require focused investigation.

Purpose of the Study:

• To review unique hemostatic derangements associated with paraprotein-expressing lymphoproliferative disorders.
• To discuss the role of paraproteins in these hemostatic complications.
• To outline management strategies for paraprotein-related bleeding.

Main Methods:

• Literature review of hemostatic complications in LPDs.
• Analysis of specific paraprotein-associated hemostatic abnormalities.
• Discussion of clinical manifestations and diagnostic challenges.

Main Results:

• Paraproteins can cause fibrin polymerization inhibition, platelet dysfunction, and acquired von Willebrand factor deficiency.
• Other complications include heparin-like anticoagulants, amyloid-associated disorders, factor deficiencies, and hypercoagulable states.
• The precise role of paraproteins is often unclear, and abnormal tests may not correlate with bleeding.

Conclusions:

• Paraproteins contribute to diverse and unique hemostatic derangements in LPDs.
• Effective management necessitates understanding the underlying mechanism and specific LPD type.
• Further research is needed to elucidate the exact role of paraproteins in hemostasis.